反応式
[F:1][C:2]1[CH:10]=[N:9][CH:8]=[CH:7][C:3]=1[C:4]([OH:6])=O.ClC1N=C(OC)N=C(OC)[N:13]=1.CN1CCOCC1.[Cl:29][C:30]1[C:31]([C:40]2[CH:45]=[CH:44][C:43](N)=[CH:42][CH:41]=2)=[CH:32][C:33]2[O:37][C:36]([CH3:38])=[N:35][C:34]=2[CH:39]=1.C([O-])(O)=O.[Na+].CC(=O)OCC>C(Cl)Cl>[Cl:29][C:30]1[C:31]([C:40]2[CH:45]=[CH:44][CH:43]=[C:42]([NH:13][C:4]([C:3]3[CH:7]=[CH:8][N:9]=[CH:10][C:2]=3[F:1])=[O:6])[CH:41]=2)=[CH:32][C:33]2[O:37][C:36]([CH3:38])=[N:35][C:34]=2[CH:39]=1参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
A suspension of 3-fluoroisonicotinic acid (20 mg, 0.14 mmol), 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) (28 mg, 0.16 mmol) and 40 μl N-methyl morpholine in 1 ml DCM was stirred at r.t. for 1 h before addition of 56 (20 mg, 0.078 mmol). The resulting reaction mixture was stirred at r.t. for overnight. The reaction mixture was worked up with aq. NaHCO3/EA. Org. phase was washed with brine, concentrated, subjected to silica flash column chromatography to furnish 28.5 mg title compound 60 as off-white solid. (Yield: 95.7%).
後処理
- customThe resulting reaction mixture
- washphase was washed with brine
- concentrationconcentrated
出典と根拠
- ORDレコード
- ord-88aed97be0df4e2c8b6be259ac849e52
- 出典データセット
- uspto-grants-2014_06
- 特許番号
- US08754219B2
関連ノート
読み込み中…